Clinical Laserthermia Systems
17.18 SEK -6.27%1 investor is following this company
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Revenue
8.27M
EBIT %
-797.22 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CLS B
Daily low / high price
16.33 / 19.398
SEK
Market cap
134.89M SEK
Turnover
529.71K SEK
Volume
30K
Financial calendar
Interim report
2024-05-17
General meeting
2024-06-28
Interim report
2024-08-23
Interim report
2024-11-15
Annual report
2025-02-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7.1 % | 6.8 % |
Handelsbanken Liv Försäkringsaktiebolag | 4.7 % | 4.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
CLS: Clinical Laserthermia Systems offentliggör tidsplan och ytterligare information inför förestående sammanläggning av aktier
CLS: Kommuniké från extra bolagsstämma fredagen den 12 april i Clinical Laserthermia Systems AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools